---
title: "Sam Altman confirms OpenAI won't go public this year saying \"given everything happening with safety, right now would be an ill-advised moment to go public\" (Jason Ma/Fortune)"
type: signal
url: https://frontiernewswire.com/s/sam-altman-confirms-openai-wont-go-public-this-year-saying-given-6b511494
published: 2026-09-12T19:35:05.000Z
byline: "Source: TECHMEME"
---

# Sam Altman confirms OpenAI won't go public this year saying "given everything happening with safety, right now would be an ill-advised moment to go public" (Jason Ma/Fortune)

Source: TECHMEME · Published 2026-09-12 · Canonical: https://frontiernewswire.com/s/sam-altman-confirms-openai-wont-go-public-this-year-saying-given-6b511494

Jason Ma / Fortune : Sam Altman confirms OpenAI won't go public this year saying "given everything happening with safety, right now would be an ill-advised moment to go public" — Wall Street will have to wait for one of the most highly anticipated initial public offerings as OpenAI CEO Sam Altman confirmed it will not happen in 2026.

In this story: [Fortune](https://frontiernewswire.com/companies/fortune)

## Sources

- [Read the original at TECHMEME](https://www.techmeme.com/260912/p16#a260912p16)

## Related on Frontier

- [Filing: Anthropic plans to raise up to $3.5B from Japanese investors as part of its IPO, joining Australia, Canada, and parts of Europe in having direct access (Yasutaka Tamura/Bloomberg)](https://frontiernewswire.com/s/filing-anthropic-plans-to-raise-up-to-3-5b-from-japanese-investors-as-4f01a21f)
- [Pharmaceutical leaders are skeptical of claims that AI could cure most diseases within a decade; the US FDA has yet to clear any AI-designed biotech drugs (Xavier Martinez/Wall Street Journal)](https://frontiernewswire.com/s/pharmaceutical-leaders-are-skeptical-of-claims-that-ai-could-cure-most-aee06777)

---

[More Latest Signal](https://frontiernewswire.com/) · [Signals](https://frontiernewswire.com/verified-reporting)